Analysis shows dotinurad is effective and safe, reducing hyperuricemia in patients with Stage B/C heart failure.
Switching from febuxostat to dotinurad may be effective and safe over the short term in patients with Stage B/C heart failure and hyperuricemia.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: